Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 2788-2792, May 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beamer, W. G.
Right arrow Articles by Tennent, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beamer, W. G.
Right arrow Articles by Tennent, B. J.

Induction of Ovarian Granulosa Cell Tumors in SWXJ-9 Mice with Dehydroepiandrosterone1

Wesley G. Beamer, Kathryn L. Shultz and Barbara J. Tennent

The Jackson Laboratory,2 Bar Harbor, Maine 04609

Spontaneous ovarian granulosa cell (GC) tumors develop in SWXJ-9 inbred mice at approximately the time of puberty. The effect of dehydroepiandrosterone (DHEA), a steroid secreted by the adrenals and reported to have antitumor actions, was examined in this ovarian tumor model. In contrast with expectations, administration of diet supplemented with 0.4% DHEA or Silastic capsules containing 10 mg DHEA resulted in a significant multifold increase in GC tumor incidence. Similar studies with metabolites of DHEA, i.e., testosterone (TESTO), dihydrotestosterone (DHT), and 17ß-estradiol (E2), revealed that TESTO was as effective as DHEA in increasing GC tumor incidence. DHT was without effect, and E2 suppressed GC tumor incidence.

Serum steroid levels and steroid target tissue responses were assessed to determine if a correlation between a change in level or response to specific steroids and GC tumorigenesis existed. In both tumor-free and GC tumor host mice, dietary or capsular treatment with DHEA, TESTO, or DHT resulted in substantial alteration in one or more of serum steroids, DHEA, androstenedione, TESTO, and DHT, in addition to the administered steroid. No consistent correlation was observed between changes in a single steroid or pattern of steroids and GC tumorigenesis. Although significant increases in serum estrogens could be detected in GC tumor hosts treated with DHEA but not TESTO, estrogens did not induce these tumors. Treatment with E2 increased only serum E2 levels. In tumor-free mice, DHEA and E2 treatments were associated with vaginal cytological evidence of estrogen action, whereas the androgens induced a leukocytic pattern. Eighty-eight % of GC tumor host mice, regardless of steroid treatment, showed a vaginal cytology pattern that included cornified cells.

The evidence presented in this report leads us to hypothesize that (a) spontaneous and steroid-induced GC tumorigenesis in these mice have the same mechanism, and (b) subtle increases in DHEA or a closely related metabolite during the peripubertal period may initiate GC tumors in these genetically susceptible mice. The mechanism whereby these steroids initiate GC tumorigenesis remains to be determined.

1 This research was supported by American Cancer Society Grant CD-265 and National Cancer Institute Grant CA-24145 (W. G. B.) and by NIH National Research Service Award T32-CA-09217 (B. J. T.). Its contents are solely the responsibility of the authors and The Jackson Laboratory.

2 The Jackson Laboratory is fully accredited by the American Association for Accreditation of Laboratory Animal Care.

Received 8/25/87. Revised 12/22/87. Accepted 2/15/88.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
A. M Dorward, K. L Shultz, and W. G Beamer
LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 369 - 379.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, L. Dossus, A. Lukanova, P. H.M. Peeters, N. E. Allen, T. Key, S. Bingham, K.-T. Khaw, D. Trichopoulos, A. Trichopoulou, et al.
Endogenous Androgens and Risk of Epithelial Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Dorward, K. L. Shultz, L. G. Horton, R. Li, G. A. Churchill, and W. G. Beamer
Distal Chr 4 Harbors a Genetic Locus (Gct1) Fundamental for Spontaneous Ovarian Granulosa Cell Tumorigenesis in a Mouse Model
Cancer Res., February 15, 2005; 65(4): 1259 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Dorward, K. L. Shultz, C. L. Ackert-Bicknell, E. M. Eicher, and W. G. Beamer
High-Resolution Genetic Map of X-Linked Juvenile-Type Granulosa Cell Tumor Susceptibility Genes in Mouse
Cancer Res., December 1, 2003; 63(23): 8197 - 8202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. E. Owens, R. A. Keri, and J. H. Nilson
Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome
Mol. Endocrinol., June 1, 2002; 16(6): 1230 - 1242.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. A. Rahman and I. T. Huhtaniemi
Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin {{alpha}} Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects
Biol Reprod, April 1, 2001; 64(4): 1122 - 1130.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Amsterdam and N. Selvaraj
Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes
Endocr. Rev., August 1, 1997; 18(4): 435 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.